Lyra Therapeutics (LYRA) Misses Q3 EPS by 338c

Lyra Therapeutics (NASDAQ: LYRA) reported Q3 EPS of ($3.38).

For earnings history and earnings-related data on Lyra Therapeutics (LYRA) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• nCino, Inc. (NCNO) Reports Q2 EPS of $0.05, Offers Guidance
• Alphabet (GOOGL) Reiterated at Market Outperform by Citizens on GCP Growth, Leading Margins